A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA’s website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days. The panel, “Innovations and Challenges in Prostate Cancer,” will not be webcast.
About ESSA Pharma Inc .
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essaphrma.com, and follow us on X and LinkedIn.
Contacts
ESSA Pharma Inc.
778.331.0962
pvirsik@essapharma.com
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
https://i-invdn-com.investing.com/news/international_newspapers_69x52._800x533_L_1419494241.jpg
Source link
Investing.com